deltatrials
Completed PHASE2 INTERVENTIONAL 4-arm NCT01780883

Melatonin Dose-effect Relation in Childhood Autism (MELADOSE)

Sponsor: Centre Hospitalier Guillaume Régnier, RENNES

Updated 7 times since 2017 Last updated: Jan 17, 2025 Started: Feb 28, 2013 Primary completion: Jul 31, 2013 Completion: Sep 30, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01780883, this PHASE2 trial focuses on Childhood Autism and remains completed. Sponsored by Centre Hospitalier Guillaume Régnier, RENNES, it has been updated 7 times since 2013, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jun 2023 · 29 months · monthly snapshotCompleted~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotCompleted~Feb 2025 – present · 17 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Feb 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Feb 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jun 2023 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jan 2021 — Jun 2023 [monthly]

    Completed PHASE2

Show 2 earlier versions
  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier Guillaume Régnier, RENNES
  • Rennes University Hospital
Data source: Rennes University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .